Pages that link to "Q21134099"
Jump to navigation
Jump to search
The following pages link to Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13) (Q21134099):
Displaying 45 items.
- Addiction science: Uncovering neurobiological complexity (Q22251251) (← links)
- RNA-binding proteins, neural development and the addictions (Q26773909) (← links)
- An animal model of differential genetic risk for methamphetamine intake (Q26781680) (← links)
- A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders (Q28080064) (← links)
- A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial (Q28550547) (← links)
- A gene-based association method for mapping traits using reference transcriptome data (Q28608356) (← links)
- Amphetamine increases activity but not exploration in humans and mice (Q30367024) (← links)
- Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice (Q30826632) (← links)
- Interrogation of allelic chromatin states in human cells by high-density ChIP-genotyping. (Q34212670) (← links)
- Genetic background of extreme violent behavior (Q34445116) (← links)
- A common copy number variation (CNV) polymorphism in the CNTNAP4 gene: association with aging in females (Q35040332) (← links)
- Schizophrenia gene expression profile reverted to normal levels by antipsychotics (Q35179019) (← links)
- Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease (Q35565624) (← links)
- Cadherin-based transsynaptic networks in establishing and modifying neural connectivity. (Q35565916) (← links)
- Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations (Q35858745) (← links)
- CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis (Q35859127) (← links)
- Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses (Q35889491) (← links)
- Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors (Q36205750) (← links)
- Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers (Q36436873) (← links)
- Does COMT genotype influence the effects of d-amphetamine on executive functioning? (Q36557196) (← links)
- A proximity-based method to identify genomic regions correlated with a continuously varying environmental variable (Q36590631) (← links)
- Candidate gene studies of a promising intermediate phenotype: failure to replicate (Q36901154) (← links)
- Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction (Q36902998) (← links)
- Inattention, impulsive action, and subjective response to D-amphetamine (Q37204816) (← links)
- Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology (Q37309160) (← links)
- Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder (Q37316136) (← links)
- Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene (Q37397180) (← links)
- Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder (Q37725363) (← links)
- Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease (Q38662596) (← links)
- Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway (Q38699405) (← links)
- Cdh13 and AdipoQ gene knockout alter instrumental and Pavlovian drug conditioning. (Q38848009) (← links)
- Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition (Q42449033) (← links)
- Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014. (Q45022135) (← links)
- Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults (Q46575078) (← links)
- Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism. (Q47120217) (← links)
- Genome-wide meta-analysis of copy number variations with alcohol dependence (Q47770528) (← links)
- Ancestry-specific and sex-specific risk alleles identified in a genome-wide gene-by-alcohol dependence interaction study of risky sexual behaviors (Q49487202) (← links)
- Human Genetics of Addiction: New Insights and Future Directions. (Q52316078) (← links)
- The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction. (Q52318141) (← links)
- Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist (Q57805523) (← links)
- ADGRL3 (LPHN3) variants predict substance use disorder (Q61443148) (← links)
- Genetic loci for alcohol-related life events and substance-induced affective symptoms: indexing the "dark side" of addiction (Q61801091) (← links)
- Genome-wide by environment interaction studies of depressive symptoms and psychosocial stress in UK Biobank and Generation Scotland (Q61801103) (← links)
- Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride (Q90410857) (← links)
- Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence (Q90629069) (← links)